Search

everythinglearnresearchcommunity

for

Search:↓

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Ruxolitinib can help regrow hair in severe alopecia areata.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Flutamide and CPA are more effective than finasteride for treating acne in hyperandrogenic women.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Supplemental testosterone may lower liver cancer risk in hepatitis C patients.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

A patient's grey hair regained color during treatment with adalimumab.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

PRP injections are safe and effective for alopecia areata, but steroids are still the preferred treatment.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

Baricitinib is the most effective treatment for alopecia areata.